Center for Genome Engineering In the News
$1 Million IGNITE Grant Advances T-Cell Therapy Research for Rare Diseases
For people living with rare genetic diseases, treatment options can be limited, and some therapies cannot reach the parts of the body where they are needed most, including the brain. University of...
CGE, Research
From Seed Funding to Breakthroughs: CCRF Visits the Center for Genome Engineering
Early Investment in an Emerging Scientist The Children’s Cancer Research Fund (CCRF) recently visited the Center for Genome Engineering at the University of Minnesota.During...
CGE, Research, TIL
Dynamic Duo Earns Randy Shaver High Impact and Angel Award
Dynamic researchers Dr. Branden Moriarity and Dr. Beau Webber have spent years working side-by-side to advance innovative cancer therapies. That collaboration has earned them the 2026 Randy Shaver...
CGE, Research, TIL
Dreaming again: Ground Breaking TIL Trial
Read Original PostEmma Dimery was ready to dream big. It was 2013, and the then-23-year-old recent college graduate was excited to “begin” her life. She was living in her own apartment in Minneapolis...
CGE, TIL
Ribbon Cutting for TIL Lab
A milestone moment for the Center for Genome Engineering at the University of Minnesota. We celebrated the ribbon cutting of our new tumor infiltrating lymphocyte (TIL) lab to support the research of...
CGE, Research, TIL
Deadly diseases in Minnesota newborns to be targeted in new whole-genome study
Minnesota will participate in the federally funded BEACONS study, giving parents at selected health systems the option to enroll their newborns in whole genome sequencing to screen for more than 700...
CGE
Driving Discovery Forward: The Wasie Foundation’s $1 Million Match for Pediatric Cancer Research
The University of Minnesota has received a $1 million matching grant from The Wasie Foundation to advance immune cell genome engineering research focused on some of the most difficult-to-treat...
CGE
From Genome Engineering to Global Recognition: Advancing TIL Therapy Un-TIL It’s Cured
When Drs. Branden Moriarity and Beau Webber helped advance the gene-editing platform behind a recent Lancet Oncology publication, it marked a defining moment for translational cancer science at the...
CGE, TIL
How Venture Philanthropy Is Helping UMN Turn Discoveries Into Real-World Breakthroughs
Have you ever heard of Program-Related Investments—better known as PRIs?If not, you’re not alone. But these innovative investment tools are quietly solving one of the biggest problems in science and...
CGE, TIL
University of Minnesota Launches “Until It’s Cured” Alliance Following Breakthrough Cancer Trial
A groundbreaking clinical trial at the University of Minnesota is opening new doors in the fight against cancer. Dr. Beau Webber recently joined Midwest Access KTTC to share how his team is...
CGE, TIL
Staff with Purpose and Passion: Steph Kennelly
A career path often unfolds in a predictable, linear fashion. But for Steph Kennelly, her professional journey took a dramatic turn—one that was unexpected yet profoundly purposeful. A proud alum of...
CGE
From Small-Town Roots to Scientific Breakthroughs: Branden Moriarity and Beau Webber Featured on Minnesota Live
Dr. Branden Moriarity and Dr. Beau Webber appeared on Minnesota Live (KSTP-TV) to talk about their team’s recent clinical progress—and the future of genome...
CGE, TIL
Breakthrough Cancer Research: Dr. Branden Moriarity Shares Hope on FOX 9
This week, Dr. Branden Moriarity from the University of Minnesota’s Center for Genome Engineering joined FOX 9’s Good Day to discuss a groundbreaking approach...
CGE, TIL
Radio Spotlight on Breakthrough Cancer Research at the University of Minnesota
Dr. Branden Moriarity from the Center for Genome Engineering at the University of Minnesota joined local radio to share exciting news: the official kickoff of a bold new cancer research campaign, The...
CGE, TIL
Minnesota's Center for Genome Engineering makes breakthrough in cancer research
The team at the University of Minnesota’s Center for Genome Engineering was honored to be featured by WCCO for our work on a promising new cancer therapy. The segment highlighted a groundbreaking...
CGE, TIL
Inside the Center
Do you have feedback or something you'd like us to add to the next newsletter?
